Ethyfos 500mg Injection is a medication containing Ethyol (amifostine) as its active ingredient. Amifostine is a cytoprotective agent, meaning it helps protect healthy cells from damage caused by chemotherapy and radiation therapy. It works by being metabolized into a free thiol compound that can scavenge free radicals, which are harmful molecules generated during these treatments. This protective action can help reduce the severity of certain side effects, such as dry mouth and radiation-induced xerostomia (dryness of the mouth), and can also mitigate nephrotoxicity (kidney damage) associated with some chemotherapy drugs like cisplatin.
Ethyfos 500mg Injection is indicated for reducing the incidence of severe thrombocytopenia (low platelet count) and mucositis (inflammation of the mucous membranes) in patients with advanced squamous cell carcinoma of the head and neck cancer receiving radiation therapy, and for reducing the incidence of severe nephrotoxicity in patients with advanced ovarian cancer receiving cisplatin. The dosage and administration should be strictly determined by a qualified healthcare professional based on the patient’s condition and treatment regimen. Common side effects may include nausea, vomiting, dizziness, and transient hypotension (low blood pressure). It is crucial to store Ethyfos 500mg Injection as per the manufacturer’s instructions, typically at room temperature and protected from light.
